Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

INDUSTRY 3 OTHER 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Cyclophosphamide 423 Trastuzumab 414 Paclitaxel 375 Docetaxel 314 Capecitabine 265 Letrozole 262 Carboplatin 257 Doxorubicin 213 Tamoxifen 184 Fulvestrant 176 Epirubicin 176 Radiotherapy 171 Anastrozole 164 pembrolizumab 152 pertuzumab 147 Surveys and Questionnaires 145 Exercise 142 exemestane 128 Vinorelbine 127 palbociclib 124 Bevacizumab 123 Magnetic Resonance Spectroscopy 120 Blood Specimen Collection 120 Drug Therapy 106 Albumin-Bound Paclitaxel 105 Gemcitabine 99 130-nm albumin-bound paclitaxel 98 pyrotinib 92 eribulin 90 Biopsy 88

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × glembatumumab vedotin × Breast × Clear all

NCT03473691 2024-12-09

Breast50

University of Virginia

Phase EARLY_PHASE1 Withdrawn

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡